Merkel Cell Carcinoma Market is driven by Immunotherapy Advances
The Merkel Cell Carcinoma Market encompasses innovative immunotherapies, targeted antibodies, and combination treatments designed to address a rare but aggressive skin cancer characterized by rapid growth and high metastatic potential. Products include PD-1/PD-L1 inhibitors, oncolytic viral therapies, and adjuvant biologics that improve patient outcomes by enhancing immune recognition of tumor...
0 Kommentare 0 Anteile 47 Ansichten 0 Vorschau